Carl Sterritt
Amministratore Delegato presso Phosphate Therapeutics Ltd.
Profilo
Carl Sterritt is the founder of Shield Holdings AG and Shield Therapeutics Plc, both founded in 2008.
At Shield Holdings AG, he held the title of Chief Executive Officer & Director from 2011 to 2015.
At Shield Therapeutics Plc, he held the title of Chief Executive Officer & Executive Director from 2008 to 2020.
Currently, he is the Chief Executive Officer at Phosphate Therapeutics Ltd.
He previously held the title of Director-European Commercial Operations at Encysive Pharmaceuticals, Inc. and Senior Vice President-Commercial Development at United Therapeutics Corp.
Posizioni attive di Carl Sterritt
| Società | Posizione | Inizio |
|---|---|---|
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Amministratore Delegato | - |
Precedenti posizioni note di Carl Sterritt
| Società | Posizione | Fine |
|---|---|---|
| SHIELD THERAPEUTICS PLC | Fondatore | 22/04/2020 |
| UNITED THERAPEUTICS CORPORATION | Corporate Officer/Principal | - |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Shield Holdings AG
 Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| UNITED THERAPEUTICS CORPORATION | Health Technology |
| SHIELD THERAPEUTICS PLC | Health Technology |
| Aziende private | 3 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Health Technology |
Shield Holdings AG
Shield Holdings AG Pharmaceuticals: MajorHealth Technology Shield Holdings AG develops and commercializes late stage pharma products. The company was founded by Carl Sterritt and Christian Schweiger in 2008 and is headquartered in Wollerau, Switzerland. | Health Technology |
Phosphate Therapeutics Ltd.
Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Carl Sterritt
